Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25µg
Dosage Form: Suspension for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Vaccines and Diagnostics S.r.l, Sovicille, Italy
Note: This consent is valid for two years from the date of publication of this notice.
Product: Myambutol
Active Ingredient: Ethambutol hydrochloride 100mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Custom Pharmaceuticals Limited (UK), Hove, United Kingdom
Note: This consent is valid for two years from the date of publication of this notice.
Product: Myambutol
Active Ingredient: Ethambutol hydrochloride 400mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Cadila Pharmaceuticals Limited, Ahmedabad, India
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 15th day of July 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).